In addition, the Glasgow prognostic score (GPS) [7,8,9], defined based on C-reactive protein (CRP; 1.0 mg/dL) and serum albumin (3.5 g/dL) levels, was shown to be an important and useful nutritional assessment tool for predicting prognosis in patients with malignant tumors. The gene discussed is CRP; the disease is cancer.